Displaying 1 to 17 of 17 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
Align Technology Inc |
United States | N/A Active |
|||
Arena Pharmaceuticals Inc |
United States | 1 Jun 2009 | Series A Active |
||
CardioMEMS Inc Medical device company that develops wireless medical pressure sensors. |
United States | 9 Oct 2009 | Series F Initial investment. Round participant. Active |
||
CardioMEMS Inc Medical device company that develops wireless medical pressure sensors. |
United States | 1 Dec 2007 | Series E Initial investment. Round participant. Active |
||
Curon Medical Inc |
United States | N/A |
|||
Inhibitex Inc |
United States | N/A |
|||
Metabolex Inc Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. |
United States | 1 Apr 2007 | Series D |
||
MiddleBrook Pharmaceuticals Inc A pharmaceutical company engages in the development and commercialization of anti-infective drug products. |
United States | N/A |
|||
Novare Surgical Systems Inc |
United States | 1 Oct 2006 | Series D |
||
NxStage Medical Inc Hemofiltration for kidney failure |
N/A |
||||
Optimer Pharmaceuticals Inc Global biopharmaceutical company. |
United States | N/A |
|||
Pacific Biosciences of California Inc Provider of an integrated platform for genetic analysis. |
United States | 1 Oct 2009 | Series E |
||
Pacific Biosciences of California Inc Provider of an integrated platform for genetic analysis. |
United States | 1 Jul 2010 | Series F |
||
Salix Pharmaceuticals Inc US specialty pharmaceutical company |
United States | N/A Active |
|||
Sunesis Pharmaceuticals Inc Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he |
United States | N/A |
|||
Tengion Inc A leading regenerative medicine company. |
United States | 1 Oct 2007 | Series C Initial investment. Round participant. Active |
||
VIA Pharmaceuticals Inc Drug development company targeting vascular inflammation. |
United States | N/A |